Stock listing
HKEX:6872 TenNor Therapeutics Suzhou Ltd. (丹諾醫藥) 股價
Follow TenNor Therapeutics Suzhou Ltd. into a list and get an email when it puts out news.
Share price · HKEX:6872
$65.20 HKD -0.75 (-1.1%)
Close on Nov 3, 2026
- Day range
- $62.25 – $75.80 HKDNov 3, 2026
- Volume
- 229,600 sharesNov 3, 2026
- Market cap
- $3.41B HKDAt the close on Nov 3, 2026 · price × 52.32M shares outstanding
- Traded on an average day
- $13.80M HKDMedian day 69,850 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · HKEX:6872 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $65.20 | -0.75 | -1.1% | $65.95 | $75.80 | $62.25 | 229,600 | |
| $65.95 | -4.25 | -6.1% | $65.05 | $70.15 | $65.05 | 48,850 | |
| $70.20 | -4.80 | -6.4% | $75.00 | $75.00 | $67.70 | 98,832 | |
| $75.00 | -5.20 | -6.5% | $82.00 | $82.00 | $65.60 | 87,250 | |
| $80.20 | -3.85 | -4.6% | $86.35 | $88.60 | $78.60 | 90,550 | |
| $84.05 | -9.35 | -10.0% | $93.55 | $109.10 | $82.50 | 374,500 | |
| $93.40 | -2.35 | -2.5% | $95.40 | $95.80 | $91.00 | 55,350 | |
| $95.75 | -5.95 | -5.9% | $98.00 | $103.00 | $94.00 | 35,800 | |
| $101.70 | +1.00 | +1.0% | $108.40 | $109.00 | $98.60 | 40,850 | |
| $100.70 | -2.40 | -2.3% | $110.00 | $110.00 | $100.00 | 20,750 | |
| $103.10 | +1.40 | +1.4% | $102.20 | $105.80 | $101.30 | 21,900 | |
| $101.70 | -2.00 | -1.9% | $98.25 | $124.40 | $98.25 | 154,850 | |
| $103.70 | +0.10 | +0.1% | $108.90 | $108.90 | $101.00 | 24,250 | |
| $103.60 | -2.80 | -2.6% | $107.40 | $107.70 | $103.00 | 22,400 | |
| $106.40 | +3.60 | +3.5% | $102.00 | $123.40 | $96.70 | 209,500 | |
| $102.80 | -3.30 | -3.1% | $106.20 | $106.40 | $98.30 | 58,800 | |
| $106.10 | -1.90 | -1.8% | $108.60 | $109.70 | $102.90 | 86,900 | |
| $108.00 | -6.50 | -5.7% | $114.80 | $115.50 | $106.10 | 85,450 | |
| $114.50 | +1.50 | +1.3% | $112.90 | $114.80 | $111.40 | 32,500 | |
| $113.00 | +0.90 | +0.8% | $112.50 | $114.80 | $109.30 | 37,150 | |
| $112.10 | 0.00 | 0.0% | $112.20 | $113.00 | $109.50 | 37,000 | |
| $112.10 | -3.20 | -2.8% | $115.60 | $116.50 | $110.50 | 43,263 | |
| $115.30 | -0.80 | -0.7% | $116.20 | $118.50 | $115.10 | 69,750 | |
| $116.10 | +1.70 | +1.5% | $115.50 | $120.40 | $114.00 | 135,950 | |
| $114.40 | -6.00 | -5.0% | $120.70 | $122.20 | $104.00 | 177,950 | |
| $120.40 | -3.20 | -2.6% | $123.90 | $124.20 | $117.80 | 68,650 | |
| $123.60 | -3.00 | -2.4% | $126.60 | $127.30 | $121.50 | 108,600 | |
| $126.60 | -4.30 | -3.3% | $132.40 | $133.80 | $125.50 | 220,500 | |
| $130.90 | +3.20 | +2.5% | $128.60 | $135.70 | $117.30 | 521,650 | |
| $127.70 | +5.00 | +4.1% | $123.40 | $127.70 | $113.60 | 330,050 | |
| $122.70 | +0.80 | +0.7% | $122.40 | $129.00 | $120.20 | 231,500 | |
| $121.90 | +2.10 | +1.8% | $119.00 | $126.30 | $115.50 | 142,850 | |
| $119.80 | -3.20 | -2.6% | $128.00 | $130.10 | $113.30 | 151,650 | |
| $123.00 | -2.00 | -1.6% | $126.30 | $127.40 | $118.90 | 137,600 | |
| $125.00 | 0.00 | 0.0% | $132.20 | $134.20 | $115.60 | 140,400 | |
| $125.00 | -11.40 | -8.4% | $135.00 | $137.00 | $125.00 | 77,750 | |
| $136.40 | -13.40 | -8.9% | $148.60 | $158.00 | $132.30 | 176,150 | |
| $149.80 | -17.20 | -10.3% | $167.00 | $167.80 | $148.10 | 125,800 | |
| $167.00 | +12.70 | +8.2% | $154.60 | $172.00 | $143.60 | 204,950 | |
| $154.30 | -13.70 | -8.2% | $168.40 | $195.50 | $149.90 | 174,250 | |
| $168.00 | -5.80 | -3.3% | $173.00 | $174.20 | $165.70 | 53,950 | |
| $173.80 | -12.70 | -6.8% | $186.70 | $189.40 | $169.60 | 51,339 | |
| $186.50 | +0.30 | +0.2% | $186.50 | $187.30 | $183.10 | 36,300 | |
| $186.20 | -2.00 | -1.1% | $188.40 | $188.80 | $178.60 | 34,450 | |
| $188.20 | 0.00 | 0.0% | $188.40 | $191.00 | $184.10 | 43,150 | |
| $188.20 | -8.10 | -4.1% | $196.50 | $198.50 | $186.40 | 41,200 | |
| $196.30 | +1.10 | +0.6% | $195.40 | $199.40 | $191.90 | 59,450 | |
| $195.20 | +2.60 | +1.3% | $192.00 | $197.00 | $190.30 | 53,750 | |
| $192.60 | -8.00 | -4.0% | $200.80 | $206.00 | $190.70 | 66,600 | |
| $200.60 | +2.50 | +1.3% | $196.10 | $202.40 | $187.10 | 65,950 | |
| $198.10 | +6.10 | +3.2% | $192.50 | $198.10 | $180.50 | 69,850 | |
| $192.00 | +12.20 | +6.8% | $179.40 | $192.00 | $179.40 | 102,940 | |
| $179.80 | -10.20 | -5.4% | $190.50 | $191.10 | $162.50 | 115,595 | |
| $190.00 | -17.40 | -8.4% | $207.40 | $208.00 | $183.20 | 90,650 | |
| $207.40 | +8.30 | +4.2% | $198.10 | $210.40 | $193.00 | 64,600 | |
| $199.10 | -0.40 | -0.2% | $199.80 | $203.60 | $196.80 | 60,700 | |
| $199.50 | +2.00 | +1.0% | $197.70 | $208.00 | $190.00 | 71,350 | |
| $197.50 | +0.50 | +0.3% | $196.00 | $199.30 | $187.60 | 51,350 | |
| $197.00 | -0.70 | -0.4% | $198.00 | $205.80 | $194.50 | 83,200 | |
| $197.70 | +7.20 | +3.8% | $190.50 | $204.80 | $188.40 | 87,050 | |
| $190.50 | +3.40 | +1.8% | $187.20 | $196.80 | $185.10 | 68,050 | |
| $187.10 | +2.40 | +1.3% | $184.70 | $190.80 | $183.50 | 56,950 | |
| $184.70 | +7.40 | +4.2% | $176.30 | $184.70 | $174.00 | 61,387 | |
| $177.30 | +5.50 | +3.2% | $171.80 | $181.10 | $169.00 | 63,250 | |
| $171.80 | +11.50 | +7.2% | $159.30 | $172.40 | $159.30 | 72,210 |
- Ticker
- HKEX:6872
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Nov 4, 2026
Next Day Disclosure Returns
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 2, 2026
Closed $65.20 (-1.1%) on Nov 3, 2026
Voluntary announcement development of rifaquizinone (TNP-2092) administered via intra-articular injection for the treatment of prosthetic joint infection as a priority indication
Oct 30, 2026
Closed $70.20 (-6.4%) on Oct 30, 2026
Voluntary announcement h share repurchase plan
Oct 26, 2026
Closed $84.05 (-10.0%) on Oct 27, 2026
Articles of Association
Oct 23, 2026
Closed $93.40 (-2.5%) on Oct 26, 2026
Poll results of the 2026 second extraordinary general meeting held on Friday, October 23, 2026 and amendments to the articles of association
Oct 23, 2026
Closed $93.40 (-2.5%) on Oct 26, 2026
Voluntary announcement completion of enrollment of the first patient in the multi-center Phase IIb clinical trial of rifaquizinone (TNP-2092) administered via intra-articular injection for the treatment of prosthetic joint infection
Oct 22, 2026
Closed $95.75 (-5.9%) on Oct 23, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 2, 2026
Closed $112.10 (0.0%) on Oct 5, 2026
Form of proxy for 2026 second extraordinary general meeting to be held on October 23, 2026
Oct 2, 2026
Closed $112.10 (0.0%) on Oct 5, 2026
Notice of 2026 second extraordinary general meeting
Oct 2, 2026
Closed $112.10 (0.0%) on Oct 5, 2026
TenNor Therapeutics Suzhou Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 16 in all · newest Nov 4, 2026 · oldest 2026
Log in to ask 6ix AI your own questions about TenNor Therapeutics Suzhou Ltd.